| Literature DB >> 20565256 |
Milena Botelho Pereira Soares1, Ricardo Santana de Lima, Leonardo Lima Rocha, Juliana Fraga Vasconcelos, Silvia Regina Rogatto, Ricardo Ribeiro dos Santos, Sanda Iacobas, Regina Coeli Goldenberg, Dumitru Andrei Iacobas, Herbert Bernard Tanowitz, Antonio Carlos Campos de Carvalho, David Conover Spray.
Abstract
Chronic chagasic cardiomyopathy is a leading cause of heart failure in Latin American countries. About 30% of Trypanosoma cruzi-infected individuals develop this severe symptomatic form of the disease, characterized by intense inflammatory response accompanied by fibrosis in the heart. We performed an extensive microarray analysis of hearts from a mouse model of this disease and identified significant alterations in expression of approximately 12% of the sampled genes. Extensive up-regulations were associated with immune-inflammatory responses (chemokines, adhesion molecules, cathepsins, and major histocompatibility complex molecules) and fibrosis (extracellular matrix components, lysyl oxidase, and tissue inhibitor of metalloproteinase 1). Our results indicate potentially relevant factors involved in the pathogenesis of the disease that may provide new therapeutic targets in chronic Chagas disease.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20565256 PMCID: PMC2897928 DOI: 10.1086/653481
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226